ExploreWatchlistsPricing
  1. JP-listed companies
  2. Nxera Pharma Co., Ltd.
  3. Financials
  4. Stockholders' equity

Nxera Pharma Co., Ltd. (4565)

Market cap
¥94.6B
P/E ratio
Nexera Pharma discovers, develops and commercializes innovative specialty pharmaceuticals to improve patient quality of life in Japan and worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Dec 31, 202560,997-10.98%
Dec 31, 202468,518+2.56%
Dec 31, 202366,810+15.32%
Dec 31, 202257,936+0.81%
Dec 31, 202157,468+9.71%
Dec 31, 202052,381+16.20%
Dec 31, 201945,078-21.94%
Dec 31, 201857,747-3.26%
Mar 31, 201859,693+46.18%
Mar 31, 201740,835+3.95%
Mar 31, 201639,283+42.95%
Mar 31, 201527,481+0.94%
Mar 31, 201427,224

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat